Formulation Development White Papers & Articles

  1. Why Emerging Drug Developers Can't Afford To Delay Analytical Development 5/21/2026

    Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.

  2. Polymorphism 101: What Early-Stage Drug Developers Need To Know To Reduce Risk 5/18/2026

    Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.

  3. How Peptides Became Cornerstones Of Modern Medicine 5/18/2026

    Peptides evolved from early chemical discoveries to transformative therapies, culminating in GLP‑1 drugs that highlight their versatility, precision, and expanding role across modern medicine.

  4. Spray Dried Biologics For Pulmonary Dosage Forms 5/15/2026

    Spray drying creates stable inhalable biologic powders with controlled particle size, enabling effective lung delivery, improved stability, and scalable production for respiratory and systemic therapies.

  5. Spray Dried Biologics For Injectable Dosage Forms 5/15/2026

    Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.

  6. Advancing ADC Development Through Integrated ADME, DDI Strategies 5/8/2026

    Discover how tailored strategies, advanced technologies, and scientifically driven decision frameworks are accelerating the successful development and regulatory readiness of next-generation ADCs.

  7. The Analytical Advantage Across The Development Lifecycle 5/7/2026

    Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.

  8. Screening For Amorphous Drug Substance 5/6/2026

    Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.

  9. Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD) 5/6/2026

    Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.

  10. What Everyone Needs To Know About Polymorphs 5/6/2026

    Build a strong foundation in solid form science — especially polymorphism — to reduce risk, control variability, and accelerate your path from development to reliable, cost-effective manufacturing.